# **GAD67 (Frontier) immunostaining with Fluoro Nissl counter**
## **(Floating)XG**
Animals
1. If needed, 150 ug colchicine should be injected into lateral ventricle or targeted tissue two days before perfusion to enhance GAD signals in the soma.

Perfusion, Agarose-embedding, Sectioning
2. Transcardially perfuse with saline followed by 4% paraformaldehyde and 0.2% picric acid with 0.1 M phosphate buffer (pH 7.2–7.3). Postfix overnight with the same fixative.
3. Remove the dura. If possible, the arachnoid membrane, the pia also.
4. Embed the brain into the 4% electrophoresis quality agarose.
5. Section the brain with vibrating blade microtome into 50-µm-thick slices and harvest them in 12 well plates containing PBS

Antibody application (Room temperature, Light shielding)
6. 10% NGS in PBS-X, 30 min on shaker
7. 1st antibody in PBS-XG, overnight on shaker.
8. PBS-X wash (quick × 1, 10 min × 2)
9. 2nd antibody in PBS-XG, 2 hr on shaker
10. PBS-X wash (quick × 1, 10 min × 2)
11. PBS wash

Counterstaining with fluorescent Nissl
12. Diluted NeuroTrace (Blue), 40-60 min.
13. PBS wash (quick × 1, 10 min × 2)

Mounting
14. Mount on gelatin-coated glass slides and Air-dry (30 min)
Coverslipping
15. Coverslip with 50% (v/v) glycerol/2.5% (w/v) DABCO in PBS.

Observation
16. Observe with epifluorescence or confocal microscopy.



# **Solutions**
**PBS-X** (total 550 ml)
<p style="text-indent:1em;"> 20% Triton X-100		8.25 ml	final 0.3%</p>
<p style="text-indent:8em;">in PBS 541.75 ml</p>

**PBS-XG** (150 ml)
<p style="text-indent:1em;">normal goat serum		1.5 ml		(final 1%)
<p style="text-indent:1em;">sodium azide		30 mg		(final 0.02%)
<p style="text-indent:8em;">in PBS-X 148.5 ml

**10%NGS in PBS-X** (5 ml)
<p style="text-indent:1em;">normal goat serum		0.45 ml		(final 10%)
<p style="text-indent:8em;">in PBS-XG 4.55ml

**1st antibody** (Yamada et al., 2001) (1 µg/ml final)
<p style="text-indent:1em;">Rb anti-GAD67/65 (Frontier Institute Cat# GAD-Rb, RRID:AB_2571698) 1:200 dil.
<p style="text-indent:8em;">in PBS-XG

**2nd antibody** (1:1000 dilution, 2 µg/ml final)
<p style="text-indent:1em;">Goat anti-rabbit IgG Alexa 488 (A-11034)
<p style="text-indent:1em;">Or
<p style="text-indent:1em;">Goat anti-rabbit IgG Alexa 633 (A-21071)
<p style="text-indent:8em;">in PBS-XG

**Diluted NeuroTrace Solution** (	NeuroTrace Blue, N-21479)
<p style="text-indent:1em;">Confocal microscopy (1:150 dilution with PBS)
<p style="text-indent:1em;">Epifluorescence microscopy (1:300 dilution with PBS)

**Reagents**
<p style="text-indent:1em;">GAD-Rb-Af260 (frontier science): 20 µg, \37,800, 50 µg, \70,200
<p style="text-indent:1em;">A-11034 (Thermo Fisher Scientific): 0.5 ml, 71,900 HUF
<p style="text-indent:1em;">A-21071 (Thermo Fisher Scientific): 0.5 ml, 71,900 HUF
<p style="text-indent:1em;">N-21479 (Invitrogen): 1 ml, \34,000
<p style="text-indent:1em;">Normal Goat Serum S-1000 (Vector labratories): 20 ml


# **References**
Yamada K, Fukaya M, Shimizu H, Sakimura K, Watanabe M (2001) NMDA receptor subunits GluRepsilon1, GluRepsilon3 and GluRzeta1 are enriched at the mossy fibre-granule cell synapse in the adult mouse cerebellum. Eur J Neurosci 13:2025-2036.
